SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2602< Well, if the Baker Brothers have to be selling, I guess today is as good a Biotech Jim-9/25/2010
2601Well, if the Baker Brothers have to be selling, I guess today is as good a day (scaram(o)uche-9/24/2010
2600>> and what is your view of the range of indications << If they picscaram(o)uche-9/17/2010
2599Cool that you're hitting investment galas... part of the new, now old, gigscaram(o)uche-9/17/2010
2598I saw the slides and heard the presentation on the IDO inhibitor from the Baird Biotech Jim-9/17/2010
2597Thanks, Sales! Not too much wording lost on this abstract....... N Engl J Med.scaram(o)uche-9/17/2010
2596Rick, a lot of new info, ~ 25% of presentation, on IDO presented at today'ssoftware salesperson19/14/2010
2595Incyte Reaches Agreement with the FDA on a Special Protocol Assessment for the Pscaram(o)uche-9/13/2010
2594>>So they don't actually show any data, or specifically state which ofBiomaven-9/4/2010
2593<< Potent, oral JAK1/2 inhibitor - Excellent selectivity against a panel otommysdad-9/3/2010
2592Will this seller run out of shares before this buyer runs out of money, or vice scaram(o)uche-9/3/2010
2591YM BioSciences granted Orphan Drug Designation for CYT387 -JAK1/2 inhibitor curscaram(o)uche-8/13/2010
2590CP-690,550, Pfizer....... little bits of interesting stuff, big-time inflammascaram(o)uche-8/13/2010
2589Got some IDO news from that, thanks!scaram(o)uche-8/9/2010
25888/5/10 cc notes 1. Opening remarks (i) 050 - - will fund 30% of future developsoftware salesperson28/5/2010
2587Second Q results. I like the JAK inhibitor co-development decision with LLY... Biotech Jim-8/5/2010
2586Study Published In 'Nature Genetics' Identifies Key Gene Linked To Bloodrkrw-7/7/2010
2585Some insider buying. CEO for 10,000, CFO 2,000.rkrw-7/6/2010
2584Turns out Actemra also had an LFT signal (quick Google). So I'm thinking thtommysdad-6/17/2010
2583ald518 is aglycosylated. just an aside.scaram(o)uche-6/17/2010
2582Well, we know that the increase in cholesterol is mechanism based, so why not? scaram(o)uche-6/17/2010
2581Liver enzyme elevation with an antibody? Really? Doesn't that almost have tommysdad-6/17/2010
2580050 inhibits IL-6 production with nanomolar potency...... New Data for Investigscaram(o)uche-6/15/2010
2579Thanks, SS, I second your comments. I wonder if Lucy Liu is not in Friedman'quantman-5/26/2010
25785/26 citi conference potential US market of MF patients has been revised upwardsoftware salesperson-5/26/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News